Cell numbers were measured by bioluminescence imaging (BLI),
CellTiter Glo (Promega, Madison, WI), or
RealTime Glo (Promega) assays, according to the manufacturer’s instructions, and read on a
GLOMAX microplate reader (Promega). Cell cycle analysis was measured with DAPI (0.5 µg/ml) and Ki67 staining (Alexa Fluor 647 Ki67 antibody, 350510, BioLegend). Apoptosis was measured using an annexin V/APC and DAPI Kit (BioLegend); total apoptotic cells were defined as annexin V
+/DAPI
++annexin V
+/DAPI
- populations. Data were acquired on a Miltenyi
MACSquant flow cytometer and data analysis was performed using FlowJo software (BD Life Sciences). For BLI in vitro imaging of luciferase expressing cells, sterile luciferin (10 µL/well from a 7.5 mg/mL stock,
VivoGlo, Promega) is added to white, 96 well plates of cells, given 5 min to reach equilibrium, and read in a
GLOMAX microplate reader (Promega). For flow cytometry, a minimum of 10,000 events was collected and gated off forward and side scatter plots.
Farrell M., Fairfield H., Karam M., D'Amico A., Murphy C.S., Falank C., Pistofidi R.S., Cao A., Marinac C.R., Dragon J.A., McGuinness L., Gartner C.G., Iorio R.D., Jachimowicz E., DeMambro V., Vary C, & Reagan M.R. (2023). Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling. eLife, 12, e81184.